Nuvation Bio Inc. NUVB

Set alert

Price alert · NUVB

All alert types
4.59 USD -0.17 -3.57%

At close

4.41 -0.18 -3.92%

Pre-market · Nov 3, 5:39 AM ET

Bid
4.59 × 1
Ask
4.60 × 1
4.59 Day range 4.85
3.92 52-week range 9.75
YTD
-48.77%
1 year
-12.07%
Open
4.80
Prev close
4.76
Mkt cap
1.61B
Vol
3.72M
Avg vol
5.35M
EPS
-0.44
P/E
0.00
Div yield
0.00%
More statistics
Low
4.59
High
4.85
Forward P/E
-306.67
Beta
1.73
Short ratio
11.57
Inst. own
67.88%
Dividend
0.00
Ex-div date
Earnings
Nov 4, 2026
50-d avg
5.63
200-d avg
5.40
1y target
13.00

1D chart

Chart tools
Interval

Signals (35)
NameTimeAgo
RSI: Oversold3:35 PM14 hours ago
SMA: Bearish3:22 PM14 hours ago
MACD: Sell Signal3:05 PM15 hours ago
MACD: Buy Signal2:42 PM15 hours ago
SMA: Bearish2:35 PM15 hours ago
SMA: Bearish2:35 PM15 hours ago
SMA: Bearish2:32 PM15 hours ago
SMA: Bearish2:32 PM15 hours ago
SMA: Bearish2:25 PM15 hours ago
SMA: Bearish2:25 PM15 hours ago
MACD: Sell Signal2:22 PM15 hours ago
RSI: Overbought2:15 PM15 hours ago
MACD: Buy Signal1:48 PM16 hours ago
MACD: Sell Signal1:40 PM16 hours ago
MACD: Buy Signal1:39 PM16 hours ago
MACD: Sell Signal1:14 PM16 hours ago
SMA: Bearish1:03 PM17 hours ago
MACD: Buy Signal12:46 PM17 hours ago
MACD: Sell Signal12:32 PM17 hours ago
RSI: Oversold12:32 PM17 hours ago

Newest 20 of 35.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 13.00 +183.2% upside
Target (low)
7.00
Target (mean)
13.00
Target (high)
21.00
Ratings (0m) 13 12 buy · 1 hold · 0 sell
  • Strong buy3
  • Buy9
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 13
  • 1 month ago 13
  • 2 months ago 12

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

NUVB analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.10333-0.13 – -0.09-0.1395+25.9%34.42M+162.4%3
Next quarter-0.09-0.09 – -0.09-0.086-4.7%45.26M+8.1%2
Current year-0.29-0.29 – -0.29-0.494+41.3%194.60M+209.4%2
Next year-0.015-0.08 – 0.05-0.29+94.8%275.55M+41.6%2

Upgrades and downgrades

The latest rating changes

NUVB analyst upgrades and downgrades
DateFirmActionFromTo
Sep 30, 2026CitigroupInitiated—Buy
Sep 16, 2026CitizensReiteratedMarket OutperformMarket Outperform
Sep 16, 2026WedbushReiteratedOutperformOutperform
Aug 21, 2026Cantor FitzgeraldInitiated—Overweight
Aug 18, 2026JP MorganInitiated—Overweight
Aug 7, 2026RBC CapitalMaintainedOutperformOutperform
Jul 27, 2026HC Wainwright & Co.MaintainedBuyBuy
Jul 23, 2026WedbushReiteratedOutperformOutperform
Jul 7, 2026RBC CapitalMaintainedOutperformOutperform
Jul 7, 2026Truist SecuritiesMaintainedBuyBuy
May 5, 2026RBC CapitalReiteratedOutperformOutperform
May 5, 2026WedbushReiteratedOutperformOutperform
May 5, 2026HC Wainwright & Co.ReiteratedBuyBuy
Apr 16, 2026WedbushReiteratedOutperformOutperform
Apr 2, 2026WedbushReiteratedOutperformOutperform
Mar 27, 2026WedbushReiteratedOutperformOutperform
Mar 3, 2026UBSMaintainedNeutralNeutral
Mar 3, 2026RBC CapitalMaintainedOutperformOutperform
Feb 10, 2026WedbushReiteratedOutperformOutperform
Jan 21, 2026RBC CapitalMaintainedOutperformOutperform
Jan 12, 2026HC Wainwright & Co.MaintainedBuyBuy
Jan 7, 2026UBSInitiated—Neutral
Dec 11, 2025HC Wainwright & Co.MaintainedBuyBuy
Dec 1, 2025HC Wainwright & Co.ReiteratedBuyBuy
Nov 24, 2025Truist SecuritiesInitiated—Buy
Nov 20, 2025CitizensMaintainedMarket OutperformMarket Outperform
Nov 19, 2025B. Riley SecuritiesInitiated—Buy
Nov 4, 2025RBC CapitalMaintainedOutperformOutperform
Nov 4, 2025CitizensMaintainedMarket OutperformMarket Outperform
Oct 13, 2025WedbushReiteratedOutperformOutperform